VitaSpring Biomedical Co. Ltd. (VSBC) stock
VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $6.58MP/E –Yield –
VitaSpring Biomedical total assets
Total assets on the balance sheet at the end of each period.
VitaSpring Biomedical's total assets was $14.82K at Jul 31, 2026. For fiscal 2026 it was $14.68K, up 2.1% from the year before. The highest annual figure on record is $3.60M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $14.68K | +2.1% |
| FY2025 | Jan 31, 2025 | $14.38K | -89.5% |
| FY2024 | Jan 31, 2024 | $137.34K | -82.1% |
| FY2023 | Jan 31, 2023 | $765.95K | -78.7% |
| FY2022 | Jan 31, 2022 | $3.60M | +1802.9% |
| FY2021 | Jan 31, 2021 | $189.40K | 0.0% |
| FY2020 | Jan 31, 2020 | $189.40K | – |
| FY2019 | Jan 31, 2019 | $0 | -100.0% |
| FY2018 | Jan 31, 2018 | $1.87K | – |
| FY2017 | Jan 31, 2017 | $0 | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $14.82K | -12.9% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $11.43K | -4.0% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $14.68K | +2.1% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $16.47K | -71.8% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $17.02K | -73.5% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $11.91K | -90.9% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $14.38K | -89.5% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $58.38K | -78.9% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $64.33K | -84.1% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $131.29K | -76.1% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $137.34K | -82.1% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $277.35K | -88.6% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $404.91K | -84.3% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $548.54K | -79.7% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $765.95K | -78.7% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $2.44M | +113.5% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $2.58M | +269.5% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $2.70M | +485.6% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $3.60M | +1802.9% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $1.14M | +3594.1% |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | $699.47K | +269.3% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $460.51K | +42265.1% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $189.40K | +15683.2% |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $30.98K | +2261.1% |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | $189.40K | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | $1.09K | -29.3% |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | $1.20K | -27.2% |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | $1.31K | -25.5% |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | $0 | -100.0% |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | $1.54K | -22.6% |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | $1.65K | -21.4% |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | $1.76K | -20.3% |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | $1.87K | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | $1.99K | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | $2.10K | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | $2.21K | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | $0 | – |
See a number that looks wrong?